| Name | FT-1518 | 
|---|
| Description | FT-1518 is a new generation selective, potent and oral bioavailable mTORC1 and mTORC2 inhibitor, and exhibits antitumor activity. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 mTORC1 mTORC2  | 
                        
| In Vitro | FT-1518 is a new generation selective, potent and oral bioavailable mTORC1 and mTORC2 inhibitor, and exhibits antitumor activity. FT-1518 displays significant growth inhibitory activity against a large panel of hematologic and solid tumor cell lines with most activities falling into low nanomolar range. FT-1518 cuases potent inhibition of the mTOR pathway biomarkers (mTORC 1 & 2 biomarkers [pAkt(S473) and pS6(S240/244) or p70 S6K), no inhibition of PI3K biomarker [pAkt(T308)] in cells[1]. | 
| In Vivo | FT-1518 exhibits dose-dependent and higher tumor growth inhibition (TGI) in multiple solid tumor xenografts[1]. | 
| References | 
| Molecular Formula | C20H26N8O | 
|---|---|
| Molecular Weight | 394.47 |